Summary
Updated Aug 30, 2026
Paul Ginocchio is CHIEF FINANCIAL OFFICER of Augmedix, Inc. (AUGX). 1 SEC Form 4 filing on record, dated 4 October 2024.
Recent Transactions
1Every recent SEC Form 4 transaction Paul Ginocchio has reported, most recent first.
Most Active Insiders Right Now
Paul Ginocchio has no co-filers on record, so these are insiders with the largest open-market activity across the market in the last 90 days.
- SGF FANG Holdings, LP - $2.04B of FANG open-market activity in the last 90 days
- BX Mozart ML-2 Holdco L.P. - $1.22B of MDLN open-market activity in the last 90 days
- BCP 8 Holdings Mozart Manager L.L.C. - $1.22B of MDLN open-market activity in the last 90 days
- Hellman & Friedman Capital Partners X (Parallel), L.P. - $1.16B of MDLN open-market activity in the last 90 days
- James Michael Chu - $1.10B of BIRK open-market activity in the last 90 days
- SUMITOMO MITSUI FINANCIAL GROUP, INC. - $995.27M of JEF open-market activity in the last 90 days
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is Paul Ginocchio?
Paul Ginocchio is a corporate insider, tracked as CHIEF FINANCIAL OFFICER of Augmedix, Inc. (AUGX). InsiderAlpha holds 1 primary Form 4 filing for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
When did Paul Ginocchio last file a Form 4?
The only primary Form 4 on record is dated 4 October 2024.
Where can I see all of Paul Ginocchio's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow Paul Ginocchio and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial
